Just days before the 12 June start of the 80th virtual American Diabetes Association meeting, continuous glucose monitoring (CGM) company Dexcom Inc. announced its G6 CGM received a new CE marking in Europe and the launch of its G6 Pro CGM in the US.
The San Diego, CA-based CGM leader also recently gained temporary permission from US regulators to market its G6 CGM device in hospitals during the COVID-19 pandemic, which Dexcom’s CEO
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?